The Depressive and Bipolar Disorder Alternative Treatment Foundation Report issue

Foundation Phase 1 Phase 2 Phase 4
Founded: New York NY United States (2011)

Organization Overview

First Clinical Trial
2012
NCT01717040
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

pioglitazone (actos) (1 trial)

Drugs in Phase 2 Trials (1)

curcumin (1 trial)

Drugs in Phase 1 Trials (2)

lamotrigine (lamictal) (1 trial)

myoinositol (1 trial)

Drugs in Other Trials (1)

uridine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bipolar Disorder (Phase 4)

Depression (Phase 4)

Disease (Phase 1)

Insulin Resistance (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5